Literature DB >> 11400236

Lymphatic malformations of the head and neck: a retrospective review and a support for staging.

M Hamoir1, I Plouin-Gaudon, P Rombaux, G Francois, A S Cornu, G Desuter, P Clapuyt, C Debauche, G Verellen, C Beguin.   

Abstract

BACKGROUND: Lymphatic malformations (LM) are rare benign congenital tumors appearing mainly in the head and neck with a considerably variable outcome. A need exists to validate a staging system, taking into account the prognosis of the malformation, including preoperative and postoperative complications, long-term sequelae, and persistence of the disease to improve parental counseling and evaluate the outcome of a surgical treatment of such tumors.
METHODS: Twenty-two patients treated for LM were selected from a series of 129 patients operated on for congenital malformations of the head and neck between 1986 and 1997 at St-Luc University Hospital, Brussels, Belgium. Their charts were reviewed retrospectively, with a special focus on the anatomic location of the lesions and all the complications reported. According to de Serres et al, LM up to now have been divided into six possible categories according to their unilateral or bilateral infrahyoid and/or suprahyoid locations.
RESULTS: Stage I (unilateral infrahyoid): nine patients, 11% of complications (without mediastinal extension: 0%, with mediastinal extension: 50%); stage II (unilateral suprahyoid): three patients, 33% of complications; stage III (unilateral suprahyoid and infrahyoid): eight patients, 75% of complications; stage V (bilateral suprahyoid and infrahyoid): two patients, 100% of complications. None of the children was initially seen with stage IV (bilateral suprahyoid) or stage VI (bilateral infrahyoid) LM. Overall complications, preoperative complications, postoperative com- plications, and long-term morbidity showed a significant in- crease from stage I to V (p <.01, p =.002, p =.02, and p =.03, respectively).
CONCLUSIONS: A staging system of cervicofacial LM based on the anatomic location can be reliably used for prognostic purposes, allowing a more accurate assessment of the global risk of complications and determination of surgical outcome. Mediastinal extension in stage I patients seems to be associated with a higher rate of complications. Such information can be used to inform parents more appropriately regarding the management and long-term prognosis of their children's malformation.

Entities:  

Mesh:

Year:  2001        PMID: 11400236     DOI: 10.1002/hed.1039

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  14 in total

1.  Cystic Hygroma in an Adult Male: A Diagnostic Challenge.

Authors:  Varsha Bhatia; Rahul Taksande; Divyaja Sondankar
Journal:  Iran J Pathol       Date:  2015

2.  OK-432 sclerotherapy of lymphatic malformation in the head and neck: factors related to outcome.

Authors:  Dong Wook Kim
Journal:  Pediatr Radiol       Date:  2014-02-26

3.  Site-specific induction of lymphatic malformations in a rat model for image-guided therapy.

Authors:  Robert F Short; William E Shiels; Thomas J Sferra; Kathleen K Nicol; Minka Schofield; Gregory J Wiet
Journal:  Pediatr Radiol       Date:  2007-03-31

4.  Treatment of lymphatic malformations of head and neck with OK-432 sclerotherapy induce systemic inflammatory response.

Authors:  Mervi Närkiö-Mäkelä; Teppo Mäkelä; Pia Saarinen; Päivi Salminen; Ilkka Julkunen; Anne Pitkäranta
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-07-16       Impact factor: 2.503

Review 5.  Imaging of pediatric floor of mouth lesions.

Authors:  Rachael M Edwards; Teresa Chapman; David L Horn; Angelisa M Paladin; Ramesh S Iyer
Journal:  Pediatr Radiol       Date:  2013-02-22

6.  [Lymphatic malformations in the head and neck region. Clinical aspects and therapeutic options].

Authors:  B Eivazi; J A Werner
Journal:  HNO       Date:  2014-01       Impact factor: 1.284

7.  A single-center experience in the management of head and neck lymphangiomas.

Authors:  Paolo Aluffi Valletti; Matteo Brucoli; Paolo Boffano; Arnaldo Benech; Andrea Toso; Valeria Dell'Era; Massimiliano Garzaro
Journal:  Oral Maxillofac Surg       Date:  2020-01-20

8.  Japanese clinical practice guidelines for vascular anomalies 2017.

Authors:  Hidefumi Mimura; Sadanori Akita; Akihiro Fujino; Masatoshi Jinnin; Mine Ozaki; Keigo Osuga; Hiroki Nakaoka; Eiichi Morii; Akira Kuramochi; Yoko Aoki; Yasunori Arai; Noriko Aramaki; Masanori Inoue; Yuki Iwashina; Tadashi Iwanaka; Shigeru Ueno; Akihiro Umezawa; Michio Ozeki; Junko Ochi; Yoshiaki Kinoshita; Masakazu Kurita; Shien Seike; Nobuyuki Takakura; Masataka Takahashi; Takao Tachibana; Kumiko Chuman; Shuji Nagata; Mitsunaga Narushima; Yasunari Niimi; Shunsuke Nosaka; Taiki Nozaki; Kazuki Hashimoto; Ayato Hayashi; Satoshi Hirakawa; Atsuko Fujikawa; Yumiko Hori; Kentaro Matsuoka; Hideki Mori; Yuki Yamamoto; Shunsuke Yuzuriha; Naoaki Rikihisa; Shoji Watanabe; Shinichi Watanabe; Tatsuo Kuroda; Shunsuke Sugawara; Kosuke Ishikawa; Satoru Sasaki
Journal:  Jpn J Radiol       Date:  2020-04       Impact factor: 2.374

9.  Japanese Clinical Practice Guidelines for Vascular Anomalies 2017.

Authors:  Hidefumi Mimura; Sadanori Akita; Akihiro Fujino; Masatoshi Jinnin; Mine Ozaki; Keigo Osuga; Hiroki Nakaoka; Eiichi Morii; Akira Kuramochi; Yoko Aoki; Yasunori Arai; Noriko Aramaki; Masanori Inoue; Yuki Iwashina; Tadashi Iwanaka; Shigeru Ueno; Akihiro Umezawa; Michio Ozeki; Junko Ochi; Yoshiaki Kinoshita; Masakazu Kurita; Shien Seike; Nobuyuki Takakura; Masataka Takahashi; Takao Tachibana; Kumiko Chuman; Shuji Nagata; Mitsunaga Narushima; Yasunari Niimi; Shunsuke Nosaka; Taiki Nozaki; Kazuki Hashimoto; Ayato Hayashi; Satoshi Hirakawa; Atsuko Fujikawa; Yumiko Hori; Kentaro Matsuoka; Hideki Mori; Yuki Yamamoto; Shunsuke Yuzuriha; Naoaki Rikihisa; Shoji Watanabe; Shinichi Watanabe; Tatsuo Kuroda; Shunsuke Sugawara; Kosuke Ishikawa; Satoru Sasaki
Journal:  J Dermatol       Date:  2020-03-22       Impact factor: 4.005

10.  Cystic hygroma in an adult; a case report.

Authors:  G Veeraraghavan; C Denny; A Lingappa
Journal:  Libyan J Med       Date:  2009-12-01       Impact factor: 1.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.